Oxytocin Acetate Peptide

Oxytocin (OXT) is a cyclic nonapeptide hormone with the sequence Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH₂, featuring a disulfide bridge between Cys1 and Cys6 that creates a 20-membered ring with a C-terminal tripeptide tail. The molecule signals through a single G-protein-coupled receptor, the oxytocin receptor (OXTR), encoded by the OXTR gene on chromosome 3p25. OXTR exhibits sub-nanomolar to low-nanomolar affinity for oxytocin, with reported K_i values in the range of 0.5-2 nM in transfected human cell systems.^[1]

Gq/11 Signaling — Primary Pathway

OXTR predominantly couples to G_q/11, activating phospholipase C-β (PLCβ), which hydrolyzes phosphatidylinositol 4,5-bisphosphate (PIP₂) into inositol trisphosphate (IP₃) and diacylglycerol (DAG). IP₃ mobilizes intracellular Ca²⁺ from endoplasmic reticulum stores, while DAG activates protein kinase C (PKC). In myometrial smooth muscle, this Ca²⁺ surge drives myosin light-chain kinase (MLCK) activation and uterine contraction. In mammary myoepithelial cells, the same cascade triggers milk ejection.

Gi/o Signaling — Secondary Pathway

At higher receptor densities or under specific cellular contexts, OXTR can couple to G_i/o, inhibiting adenylyl cyclase and reducing cAMP. This pathway has been implicated in modulating neuronal excitability and presynaptic neurotransmitter release in central oxytocin circuits, including the hypothalamic paraventricular nucleus (PVN) and supraoptic nucleus (SON).

Central Nervous System Signaling

Within the CNS, oxytocin is synthesized in magnocellular and parvocellular neurons of the PVN and SON and is released both peripherally via the posterior pituitary and centrally via somatodendritic and axonal projections to limbic structures including the amygdala, nucleus accumbens, hippocampus, and prefrontal cortex. OXTR activation in the central amygdala has been shown in preclinical models to attenuate fear responses, while accumbal OXTR-dopamine D2 receptor heterodimer formation modulates social reward processing.^[2]

Cross-Reactivity with Vasopressin Receptors

Oxytocin shares structural homology with arginine vasopressin (AVP), differing by only two residues (Ile3 vs Phe3; Leu8 vs Arg8). As a consequence, oxytocin exhibits measurable affinity for the three vasopressin receptor subtypes (V1aR, V1bR, V2R), with K_i values typically 10-100-fold higher than at OXTR. This cross-reactivity is an important confounder in interpreting research data, particularly at supraphysiological concentrations, and has driven development of selective OXTR agonists such as carbetocin and TGOT ([Thr⁴,Gly⁷]oxytocin).

Receptor Desensitization

OXTR undergoes rapid agonist-induced phosphorylation by G-protein-coupled receptor kinases (GRKs), recruitment of β-arrestin-1/2, internalization via clathrin-coated pits, and either recycling to the membrane or lysosomal degradation. This desensitization profile is relevant to research models examining tachyphylaxis during sustained oxytocin exposure.

The following table summarizes verified physicochemical data for oxytocin acetate as cataloged in PubChem and standard pharmacopoeial references. Values are provided for the free peptide; the acetate salt form has slightly higher mass due to associated acetate counterions but identical primary sequence and bioactivity.

Oxytocin is one of the smallest and most thoroughly characterized peptide hormones in pharmacology, and its synthesis by du Vigneaud in 1953 represented the first chemical synthesis of a polypeptide hormone. The disulfide bridge is essential for receptor binding affinity — reduction of the Cys1-Cys6 bond abolishes activity at OXTR.

Oxytocin acetate is supplied as a lyophilized powder and requires careful reconstitution to preserve peptide integrity. The cyclic disulfide bridge between Cys1 and Cys6 is essential for receptor binding activity, and improper handling can lead to disulfide scrambling, oxidation, or aggregation that compromises bioactivity.

Reconstitution Protocol

1. Allow the vial to reach room temperature before opening. Remove from -20°C storage and let stand at ambient temperature for 15-20 minutes to prevent moisture condensation on the lyophilized powder.
2. Select the appropriate diluent: bacteriostatic water (0.9% benzyl alcohol) is preferred for multi-use reconstitution, while sterile water for injection or 0.9% sodium chloride is suitable for single-use applications.
3. Calculate target concentration: For a 5 mg vial, add 5 mL of diluent to achieve a 1 mg/mL working solution. For higher concentrations, use 2.5 mL to obtain 2 mg/mL.
4. Inject diluent slowly down the side of the vial wall, avoiding direct impact on the lyophilized cake. Do not inject directly onto the powder.
5. Swirl gently in a circular motion until fully dissolved. Do not shake or vortex — agitation can denature the peptide and disrupt the disulfide bridge.
6. Inspect visually for complete dissolution. The solution should be clear and colorless. Any cloudiness, particulates, or discoloration indicates degradation and the vial should be discarded.

Compound-Specific Handling Notes

Disulfide bridge sensitivity: Oxytocin contains a single intramolecular disulfide bond (Cys1-Cys6) that is critical for the cyclic conformation required for OXTR binding. Exposure to reducing agents (DTT, β-mercaptoethanol, TCEP) will cleave this bridge and abolish activity. Avoid contact with metal surfaces that may catalyze oxidation.

pH considerations: Oxytocin is most stable at slightly acidic pH (3.5-4.5). Avoid alkaline buffers, which accelerate degradation via deamidation of Asn5 and Gln4 residues.

Adsorption losses: Oxytocin exhibits non-specific binding to glass and plastic surfaces, particularly at low concentrations (<10 μg/mL). For dilute working solutions, consider adding 0.1% bovine serum albumin (BSA) as a carrier protein to minimize adsorption losses.

Temperature sensitivity: Once reconstituted, maintain the solution at 2-8°C and avoid repeated warming. Use cold-chain protocols for any solution transfers.

Aliquoting Recommendations

For long-term research use, prepare single-use aliquots immediately after reconstitution to avoid freeze-thaw cycles. Use low-binding polypropylene tubes (Eppendorf Protein LoBind or equivalent) and store at -80°C for maximum stability. Each freeze-thaw cycle can reduce potency by approximately 5-10%.

Proper storage of oxytocin acetate is essential for maintaining peptide integrity and reproducible research results. The compound's stability profile is dictated by its cyclic disulfide structure, susceptibility to deamidation, and sensitivity to oxidative degradation.

Lyophilized Powder Storage

• Long-term storage (>1 month): Store at -20°C in original sealed vial with desiccant. Under these conditions, lyophilized oxytocin acetate remains stable for 24-36 months with minimal loss of potency.
• Extended long-term storage: For storage exceeding 2 years, -80°C is recommended to minimize gradual degradation pathways including aspartimide formation and disulfide scrambling.
• Short-term storage (<30 days): Stable at 2-8°C (refrigerated) when sealed and protected from moisture.
• Transit conditions: Oxytocin acetate tolerates ambient temperatures (15-25°C) for up to 7 days during shipping without significant degradation, provided the vial remains sealed.

Reconstituted Solution Stability

• Refrigerated (2-8°C): Reconstituted solutions in bacteriostatic water remain stable for 14-21 days. Solutions in sterile water without preservative should be used within 7 days.
• Frozen aliquots (-20°C or -80°C): Stable for 3-6 months in low-binding polypropylene tubes. Limit to a maximum of 2-3 freeze-thaw cycles.
• Room temperature: Reconstituted oxytocin degrades rapidly at ambient temperature, with measurable potency loss within 24-48 hours. Avoid prolonged room temperature exposure.

Degradation Pathways

Understanding oxytocin's degradation chemistry helps researchers anticipate stability issues:

• Disulfide reduction/scrambling: The Cys1-Cys6 bridge can be reduced under anaerobic conditions or scrambled in the presence of free thiols, producing inactive linear or misfolded species.
• Deamidation: Asn5 and Gln4 are susceptible to deamidation, particularly at pH >6, producing iso-aspartate and glutamate derivatives with reduced OXTR affinity.
• Oxidation: Although oxytocin lacks methionine, the disulfide bridge can undergo oxidation to sulfoxide or sulfone forms under exposure to peroxides or transition metals.
• Aggregation: At high concentrations or low pH, oxytocin can form fibrillar aggregates, particularly when subjected to mechanical stress (shaking, vortexing).

Best Practices Summary

For optimal research reproducibility: store lyophilized material at -20°C with desiccant, reconstitute only what is needed for immediate experiments, prepare single-use aliquots to avoid freeze-thaw degradation, protect from light using amber vials or foil wrapping, and verify peptide integrity periodically via HPLC or mass spectrometry for long-stored material. Always document reconstitution dates and storage history for each experimental batch.